Cargando…
Open-label placebo treatment does not enhance cognitive abilities in healthy volunteers
The use of so-called ‘smart drugs’ such as modafinil to improve cognitive performance has recently attracted considerable attention. However, their side effects have limited user enthusiasm. Open-label placebo (OLP) treatment, i.e., inert treatments that are openly disclosed to individuals as having...
Autores principales: | Hartmann, Helena, Forkmann, Katarina, Schmidt, Katharina, Kleine-Borgmann, Julian, Albers, Johanna, Wiech, Katja, Bingel, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636058/ https://www.ncbi.nlm.nih.gov/pubmed/37945662 http://dx.doi.org/10.1038/s41598-023-45979-3 |
Ejemplares similares
-
Effects of open-label placebos on test performance and psychological well-being in healthy medical students: a randomized controlled trial
por: Kleine-Borgmann, Julian, et al.
Publicado: (2021) -
Impaired pain-related threat and safety learning in patients with chronic back pain
por: Schlitt, Frederik, et al.
Publicado: (2022) -
Does pain modality play a role in the interruptive function of acute visceral compared with somatic pain?
por: Kleine-Borgmann, Julian, et al.
Publicado: (2022) -
No long-term effects after a 3-week open-label placebo treatment for chronic low back pain: a 3-year follow-up of a randomized controlled trial
por: Kleine-Borgmann, Julian, et al.
Publicado: (2023) -
Impact of a 12-week open-label placebo treatment on headache days in episodic and chronic migraine: a study protocol for a parallel-group, multicentre, randomised controlled trial
por: Schmidt, Katharina, et al.
Publicado: (2021)